These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7718488

  • 1. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
    Ehinger M, Nilsson E, Persson AM, Olsson I, Gullberg U.
    Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
    [Abstract] [Full Text] [Related]

  • 2. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
    Kremenetskaia OS, Logacheva NP, Baryshnikov AIu, Chumakov PM, Kopnin BP.
    Tsitologiia; 1996 Jan; 38(12):1280-93. PubMed ID: 9163103
    [Abstract] [Full Text] [Related]

  • 3. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
    Ehinger M, Bergh G, Johnsson E, Gullberg U, Olsson I.
    Cell Growth Differ; 1997 Oct; 8(10):1127-37. PubMed ID: 9342191
    [Abstract] [Full Text] [Related]

  • 4. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.
    Cajot JF, Anderson MJ, Lehman TA, Shapiro H, Briggs AA, Stanbridge EJ.
    Cancer Res; 1992 Dec 15; 52(24):6956-60. PubMed ID: 1458487
    [Abstract] [Full Text] [Related]

  • 5. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
    Kremenetskaya OS, Logacheva NP, Baryshnikov AY, Chumakov PM, Kopnin BP.
    Oncol Res; 1997 Dec 15; 9(4):155-66. PubMed ID: 9268986
    [Abstract] [Full Text] [Related]

  • 6. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
    Chen YZ, Wu Y, Liang M, Li NN, Zhang ZX, Lu LH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 15; 24(12):640-3. PubMed ID: 14761612
    [Abstract] [Full Text] [Related]

  • 7. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
    Rui HB, Su JZ.
    Haematologica; 2002 Feb 15; 87(2):136-42. PubMed ID: 11836163
    [Abstract] [Full Text] [Related]

  • 8. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR, Hromchak R, Mudipalli A, Bloch A.
    Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653
    [Abstract] [Full Text] [Related]

  • 9. Expression of the normal p53 gene induces differentiation of K562 cells.
    Feinstein E, Gale RP, Reed J, Canaani E.
    Oncogene; 1992 Sep 01; 7(9):1853-7. PubMed ID: 1501893
    [Abstract] [Full Text] [Related]

  • 10. Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.
    Pierce A, Spooncer E, Wooley S, Dive C, Francis JM, Miyan J, Owen-Lynch PJ, Dexter TM, Whetton AD.
    Oncogene; 2000 Nov 16; 19(48):5487-97. PubMed ID: 11114726
    [Abstract] [Full Text] [Related]

  • 11. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
    Yasuoka Y, Naomoto Y, Yamatsuji T, Takaoka M, Kimura M, Uetsuka H, Matsubara N, Fujiwara T, Gunduz M, Tanaka N, Haisa M.
    Exp Cell Res; 2001 Dec 10; 271(2):214-22. PubMed ID: 11716533
    [Abstract] [Full Text] [Related]

  • 12. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
    Aloni-Grinstein R, Zan-Bar I, Alboum I, Goldfinger N, Rotter V.
    Oncogene; 1993 Dec 10; 8(12):3297-305. PubMed ID: 8247532
    [Abstract] [Full Text] [Related]

  • 13. [The relationship of p53 and the cytotoxicity mediated by TM-TNF-alpha and S-TNF-alpha].
    Zhu J, Zheng F, Zhang J, Xiong P, Xu Y, Li ZY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar 10; 20(2):152-4. PubMed ID: 15191714
    [Abstract] [Full Text] [Related]

  • 14. Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.
    Hori M, Suzuki K, Udono MU, Yamauchi M, Mine M, Watanabe M, Kondo S, Hozumi Y.
    Arch Dermatol Res; 2009 Oct 10; 301(9):631-46. PubMed ID: 19009304
    [Abstract] [Full Text] [Related]

  • 15. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
    Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A.
    Oncogene; 1997 Feb 13; 14(6):729-40. PubMed ID: 9038381
    [Abstract] [Full Text] [Related]

  • 16. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE.
    Oncogene; 1998 Sep 03; 17(9):1119-30. PubMed ID: 9764822
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K, Ehinger M, Svedberg H, Gullberg U.
    Cell Growth Differ; 2000 Nov 03; 11(11):561-71. PubMed ID: 11095245
    [Abstract] [Full Text] [Related]

  • 18. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
    Sharma S, Schwarte-Waldhoff I, Oberhuber H, Schäfer R.
    Cell Growth Differ; 1993 Oct 03; 4(10):861-9. PubMed ID: 8274455
    [Abstract] [Full Text] [Related]

  • 19. Significance of apoptosis induced by tumor necrosis factor-alpha and/or interferon-gamma against human gastric cancer cell lines and the role of the p53 gene.
    Fukui T, Matsui K, Kato H, Takao H, Sugiyama Y, Kunieda K, Saji S.
    Surg Today; 2003 Oct 03; 33(11):847-53. PubMed ID: 14605957
    [Abstract] [Full Text] [Related]

  • 20. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G, Wiman KG.
    Oncogene; 1993 Jun 03; 8(6):1495-500. PubMed ID: 8502475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.